Have a personal or library account? Click to login
Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases Cover

Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases

Radiology and Oncology
Volume 54 (2020): Issue 1 (March 2020)
By: Katja Goricar,  Viljem Kovac,  Metoda Dodic-Fikfak,  Vita Dolzan and  Alenka Franko  
Open Access
|Mar 2020
DOI: https://doi.org/10.2478/raon-2020-0011 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 86 - 95
Published on: Mar 7, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
malignant mesothelioma,
asbestos-related disease,
mesothelin,
soluble mesothelin-related peptides,
polymorphism
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2020 Katja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, Vita Dolzan, Alenka Franko, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 54 (2020): Issue 1 (March 2020)Next article